Overview
Komtur Polska is a specialist distributor of medicinal products, including innovative therapies and orphan and specialist medicines for rare and ultra-rare diseases. It supplies clinical trials and healthcare providers with medicines, medical devices and food for special medical purposes, and provides Market Access and logistics services.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2004-12-31. Active
86 1240 6292 1207 0011 1718 8065
34 1140 0039 0000 7092 9000 1002- 61 1140 0039 0000 7092 9000 1001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 2.8MPLN 2,776,303 |
Investment property | PLN 6.3MPLN 6,303,581 |
Public aid
20 public aid cases recorded, with a total value of $68,425.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $21,074$21,074 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $19,651$19,651 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $18,994$18,994 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
1668 tenders recorded as contractor: 241 national ($16,121,578) and 1427 EU ($13,698,361,881).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 15, 2026 | Zakup i dostawa leków przeciwnowotworowych, doustnych i dożylnych, refundowanych w ramach programów lekowych oraz z katalogu chemioterapii. | –– | Wielkopolskie Centrum Onkologii Im. Marii Skłodowskiej-Curie | |
| Oct 15, 2026 | 31/26 – Dostawa produktów leczniczych | –– | Szpital Wojewódzki w Bielsku-Białej | |
| Oct 14, 2026 | Sukcesywna dostawa produktów leczniczych stosowanych w programach lekowych | –– | Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy |
Public sector contracts
Komtur Polska is the contractor in 389 public sector contracts, worth PLN 301.51m in total. They were signed with 99 public buyers. The largest number (2) were signed with Uniwersyteckie Centrum Kliniczne.
| Public buyer | Value | |
|---|---|---|
| Zespół Opieki Zdrowotnej w Busku-Zdroju | PLN 21,840 | |
| Krakowski Szpital Specjalistyczny Im. Św. Jana Pawła II | PLN 2.00 | |
| Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | PLN 1,454 | |
| Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach | PLN 0.00 | |
| Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach | PLN 86,832 |
Public procurement disputes (KIO)
Komtur Polska has been a party to 6 cases before the National Appeal Chamber (since 2015). It filed 3 appeals (2 upheld, 1 discontinued). In 3 cases it joined the proceedings as a participant.
Trademarks
Komtur Polska holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2007.
| Mark | Protected until | |
|---|---|---|
| Komtur Polska | Feb 13, 2027 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to submit declarations concerning the company’s property rights and obligations and to sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Komtur Polen Gmbh | 10,900 | $147,217.72 | 99.0909% |
Others | 100 | $1,350.62 | 0.9091% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Manatsp. z o.o. | 13,506.21 USD | 100% | ||
Komtur Investments Polskasp. z o.o. | 2,109,130.20 USD | 100% | ||
Komtur Caresp. z o.o. | 6,753.11 USD | 50% |
Capital group
| Name | Ownership |
|---|---|
Komtur Pharmaceuticals Hungary Kft  | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Roche Polskasp. z o.o. | $799,694,562.77 | roche.pl | ||
| Bayersp. z o.o. | $624,313,880.67 | talent.bayer.com | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Roche Diagnostics Polskasp. z o.o. | $199,208,461.57 | roche.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Gilead Sciences Polandsp. z o.o. | $150,844,944.19 | gilead.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-03-22 | Address change (Puławska 405a, 02-801, Warszawa → Plac Farmacji 1, 02-699, Warszawa) | |
| 2018-03-22 | Share capital change (500,000.00 PLN → 550,000.00 PLN) | |
| 2017-05-09 | PKD change (Removed: 21.10.Z, 21.20.Z, 68.10.Z, 68.20.Z, 68.32.Z, 70.22.Z, 71.20.B, 72.11.Z, 72.19.Z, 74.30.Z, 82.30.Z, 82.92.Z, 85.59.B) | |
| 2011-12-12 | PKD change (Removed: 51.46.Z, 52.31.Z, 52.32.Z, 70.32.Z, 73.10.F, 74.14.B, 74.87.A, 74.87.B, 80.42.B; Added: 21.10.Z, 21.20.Z, 46.39.Z, 46.46.Z, 47.73.Z, 47.74.Z, 47.75.Z, 49.41.Z, 52.10.B, 52.24.C, 63.99.Z, 68.10.Z, 68.20.Z, 68.32.Z, 69.20.Z, 70.22.Z, 71.20.B, 72.11.Z, 72.19.Z, 74.30.Z, 82.30.Z, 82.92.Z, 85.59.B) | |
| 2007-08-09 | Share capital change (50,000.00 PLN → 500,000.00 PLN) |
FAQ
Last updated: 2026-07-21